CN102133271B - Herbal tea for treating gout - Google Patents
Herbal tea for treating gout Download PDFInfo
- Publication number
- CN102133271B CN102133271B CN2011100473355A CN201110047335A CN102133271B CN 102133271 B CN102133271 B CN 102133271B CN 2011100473355 A CN2011100473355 A CN 2011100473355A CN 201110047335 A CN201110047335 A CN 201110047335A CN 102133271 B CN102133271 B CN 102133271B
- Authority
- CN
- China
- Prior art keywords
- tea
- weight
- bright moon
- bagged
- herba plantaginis
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 201000005569 Gout Diseases 0.000 title abstract description 19
- 235000015092 herbal tea Nutrition 0.000 title 1
- 210000000582 semen Anatomy 0.000 claims abstract description 53
- 235000003143 Panax notoginseng Nutrition 0.000 claims abstract description 31
- 241000180649 Panax notoginseng Species 0.000 claims abstract description 31
- 244000269722 Thea sinensis Species 0.000 claims abstract 6
- 244000025254 Cannabis sativa Species 0.000 claims description 60
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 60
- 239000002994 raw material Substances 0.000 claims description 33
- 241000283707 Capra Species 0.000 claims description 17
- 238000012545 processing Methods 0.000 claims description 5
- 238000004519 manufacturing process Methods 0.000 abstract description 27
- 238000001035 drying Methods 0.000 abstract description 25
- 239000008280 blood Substances 0.000 abstract description 15
- 210000004369 blood Anatomy 0.000 abstract description 15
- 230000000694 effects Effects 0.000 abstract description 14
- LEHOTFFKMJEONL-UHFFFAOYSA-N Uric Acid Chemical compound N1C(=O)NC(=O)C2=C1NC(=O)N2 LEHOTFFKMJEONL-UHFFFAOYSA-N 0.000 abstract description 10
- TVWHNULVHGKJHS-UHFFFAOYSA-N Uric acid Natural products N1C(=O)NC(=O)C2NC(=O)NC21 TVWHNULVHGKJHS-UHFFFAOYSA-N 0.000 abstract description 10
- 229940116269 uric acid Drugs 0.000 abstract description 10
- 230000001737 promoting effect Effects 0.000 abstract description 8
- 230000017531 blood circulation Effects 0.000 abstract description 4
- 238000001816 cooling Methods 0.000 abstract description 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract description 3
- 241001105098 Angelica keiskei Species 0.000 abstract description 2
- 240000002853 Nelumbo nucifera Species 0.000 abstract description 2
- 235000006508 Nelumbo nucifera Nutrition 0.000 abstract description 2
- 235000015266 Plantago major Nutrition 0.000 abstract description 2
- 235000015091 medicinal tea Nutrition 0.000 abstract 2
- 235000003805 Musa ABB Group Nutrition 0.000 abstract 1
- 240000008790 Musa x paradisiaca Species 0.000 abstract 1
- 235000006510 Nelumbo pentapetala Nutrition 0.000 abstract 1
- 230000000740 bleeding effect Effects 0.000 abstract 1
- 230000027939 micturition Effects 0.000 abstract 1
- 235000013616 tea Nutrition 0.000 abstract 1
- 229940126680 traditional chinese medicines Drugs 0.000 abstract 1
- 241001122767 Theaceae Species 0.000 description 65
- 239000003814 drug Substances 0.000 description 42
- 238000000034 method Methods 0.000 description 32
- 239000000203 mixture Substances 0.000 description 27
- 238000010298 pulverizing process Methods 0.000 description 24
- KDCGOANMDULRCW-UHFFFAOYSA-N 7H-purine Chemical compound N1=CNC2=NC=NC2=C1 KDCGOANMDULRCW-UHFFFAOYSA-N 0.000 description 8
- 244000037364 Cinnamomum aromaticum Species 0.000 description 8
- 235000014489 Cinnamomum aromaticum Nutrition 0.000 description 8
- 239000000843 powder Substances 0.000 description 6
- 208000004880 Polyuria Diseases 0.000 description 4
- 230000035619 diuresis Effects 0.000 description 4
- 229940079593 drug Drugs 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- 201000001431 Hyperuricemia Diseases 0.000 description 3
- 206010003246 arthritis Diseases 0.000 description 3
- 238000003745 diagnosis Methods 0.000 description 3
- 230000023597 hemostasis Effects 0.000 description 3
- 208000024891 symptom Diseases 0.000 description 3
- IAKHMKGGTNLKSZ-INIZCTEOSA-N (S)-colchicine Chemical compound C1([C@@H](NC(C)=O)CC2)=CC(=O)C(OC)=CC=C1C1=C2C=C(OC)C(OC)=C1OC IAKHMKGGTNLKSZ-INIZCTEOSA-N 0.000 description 2
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 2
- 208000038016 acute inflammation Diseases 0.000 description 2
- 230000006022 acute inflammation Effects 0.000 description 2
- 230000033228 biological regulation Effects 0.000 description 2
- 230000036772 blood pressure Effects 0.000 description 2
- 229910052799 carbon Inorganic materials 0.000 description 2
- 235000005911 diet Nutrition 0.000 description 2
- 230000037213 diet Effects 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 230000006870 function Effects 0.000 description 2
- 229960000905 indomethacin Drugs 0.000 description 2
- CGIGDMFJXJATDK-UHFFFAOYSA-N indomethacin Chemical compound CC1=C(CC(O)=O)C2=CC(OC)=CC=C2N1C(=O)C1=CC=C(Cl)C=C1 CGIGDMFJXJATDK-UHFFFAOYSA-N 0.000 description 2
- 210000003734 kidney Anatomy 0.000 description 2
- 230000004060 metabolic process Effects 0.000 description 2
- 239000008194 pharmaceutical composition Substances 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- GOLXNESZZPUPJE-UHFFFAOYSA-N spiromesifen Chemical compound CC1=CC(C)=CC(C)=C1C(C(O1)=O)=C(OC(=O)CC(C)(C)C)C11CCCC1 GOLXNESZZPUPJE-UHFFFAOYSA-N 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- 241000563984 Ampelopsis Species 0.000 description 1
- BSYNRYMUTXBXSQ-UHFFFAOYSA-N Aspirin Chemical compound CC(=O)OC1=CC=CC=C1C(O)=O BSYNRYMUTXBXSQ-UHFFFAOYSA-N 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 244000277285 Cassia obtusifolia Species 0.000 description 1
- 235000006719 Cassia obtusifolia Nutrition 0.000 description 1
- 244000201986 Cassia tora Species 0.000 description 1
- 235000014552 Cassia tora Nutrition 0.000 description 1
- 239000000055 Corticotropin-Releasing Hormone Substances 0.000 description 1
- 241000218176 Corydalis Species 0.000 description 1
- 241000721047 Danaus plexippus Species 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 241000628997 Flos Species 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 208000008454 Hyperhidrosis Diseases 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- HEFNNWSXXWATRW-UHFFFAOYSA-N Ibuprofen Chemical compound CC(C)CC1=CC=C(C(C)C(O)=O)C=C1 HEFNNWSXXWATRW-UHFFFAOYSA-N 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 206010027336 Menstruation delayed Diseases 0.000 description 1
- 241001502129 Mullus Species 0.000 description 1
- 208000002193 Pain Diseases 0.000 description 1
- 235000002789 Panax ginseng Nutrition 0.000 description 1
- 244000131316 Panax pseudoginseng Species 0.000 description 1
- 235000003181 Panax pseudoginseng Nutrition 0.000 description 1
- 235000009388 Parthenocissus quinquefolia Nutrition 0.000 description 1
- 241001499733 Plantago asiatica Species 0.000 description 1
- 241000961970 Plantago depressa Species 0.000 description 1
- 244000010922 Plantago major Species 0.000 description 1
- 241001619461 Poria <basidiomycete fungus> Species 0.000 description 1
- 208000028017 Psychotic disease Diseases 0.000 description 1
- 241001404789 Smilax glabra Species 0.000 description 1
- UIIMBOGNXHQVGW-DEQYMQKBSA-M Sodium bicarbonate-14C Chemical compound [Na+].O[14C]([O-])=O UIIMBOGNXHQVGW-DEQYMQKBSA-M 0.000 description 1
- 229960001138 acetylsalicylic acid Drugs 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 208000026816 acute arthritis Diseases 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 208000026935 allergic disease Diseases 0.000 description 1
- 230000000172 allergic effect Effects 0.000 description 1
- 230000007815 allergy Effects 0.000 description 1
- 230000002917 arthritic effect Effects 0.000 description 1
- 208000010668 atopic eczema Diseases 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 210000000845 cartilage Anatomy 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- 229960001338 colchicine Drugs 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 238000012790 confirmation Methods 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- IDLFZVILOHSSID-OVLDLUHVSA-N corticotropin Chemical compound C([C@@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC=1NC=NC=1)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CC(N)=O)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC=1C=CC=CC=1)C(O)=O)NC(=O)[C@@H](N)CO)C1=CC=C(O)C=C1 IDLFZVILOHSSID-OVLDLUHVSA-N 0.000 description 1
- 229960000258 corticotropin Drugs 0.000 description 1
- 230000035622 drinking Effects 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000007717 exclusion Effects 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 210000003108 foot joint Anatomy 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 230000002607 hemopoietic effect Effects 0.000 description 1
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 1
- 230000037315 hyperhidrosis Effects 0.000 description 1
- 229960001680 ibuprofen Drugs 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 230000008407 joint function Effects 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 239000012567 medical material Substances 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 210000000878 metatarsophalangeal joint Anatomy 0.000 description 1
- VYQNWZOUAUKGHI-UHFFFAOYSA-N monobenzone Chemical compound C1=CC(O)=CC=C1OCC1=CC=CC=C1 VYQNWZOUAUKGHI-UHFFFAOYSA-N 0.000 description 1
- 231100000862 numbness Toxicity 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- XOFYZVNMUHMLCC-ZPOLXVRWSA-N prednisone Chemical compound O=C1C=C[C@]2(C)[C@H]3C(=O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 XOFYZVNMUHMLCC-ZPOLXVRWSA-N 0.000 description 1
- 229960004618 prednisone Drugs 0.000 description 1
- 230000035935 pregnancy Effects 0.000 description 1
- 208000037920 primary disease Diseases 0.000 description 1
- 238000010926 purge Methods 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000000452 restraining effect Effects 0.000 description 1
- 159000000000 sodium salts Chemical class 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses a medicinal tea for treating gout, which relates to the technical field of traditional Chinese medicines, and is prepared from 1-5 parts by weight of angelica keiskei, 1-5 parts by weight of plantain, 1-5 parts by weight of semen cassiae, 1-5 parts by weight of lotus leaf, 1-5 parts by weight of notoginseng flower and 1-5 parts by weight of rhizoma smilacis glabrae, and is prepared into a bagged medicinal tea by drying, crushing and uniformly mixing, and then adopting a conventional tea bag production process and bagging; the invention has the effects of clearing heat, promoting urination, reducing uric acid, cooling blood, stopping bleeding, promoting blood circulation, removing blood stasis, detoxifying, benefiting joints and the like, is convenient to take and the like, can be used for treating gout diseases, and is suitable for various gout patients to drink.
Description
Technical field
The present invention relates to the Chinese medicine technical field, particularly a kind of medicated tea of treating goat.
Background technology
Gout is claimed " hyperuricemia " again, belongs to arthritic a kind of, is that the metabolism of purine substance gets muddled in the human body; The synthetic increase of uric acid or discharge reduce; Cause hyperuricemia, during the blood uric acid excessive concentration, uric acid is deposited in joint, cartilage and the kidney with the form of sodium salt; Cause and organize foreign body inflammatory reaction, i.e. gout.At present, the western medical treatment gout mainly adopts medicines such as colchicine, indometacin, ibuprofen, ACTH and prednisone and different purine alcohol, is suitable for taking stopgap measures; The Chinese traditional treatment prescription mainly contains Aconiti Decoction plus-minus, Yougui Yin, the kidney-Yang-Reinkforcing Decotion plus-minus etc.Chinese patent disclosed " reducing the medicated tea of uric acid of patient with gout " (number of patent application is 201010262274.X); Be by Herba Lysimachiae, Herba Plantaginis, Radix Angelicae Sinensis and Folium Ilicis; Through medical material selected, dry, pulverize, according to etc. the mass ratio mix homogeneously; Adopt conventional production process of bagged tea, the bagged medicine tea that pack is processed; The medicated tea of this invention meets metabolic arthritis crowd physiological metabolism circulation characteristics; The content of uric acid in the human body can be reduced effectively,, the gout recurrence can be prevented for patient with gout; For not suffering from gout but the higher people of uric acid level; Can prevent gout, be a kind of safe uric acid resisting health herb tea, has taking convenience, mouthfeel glycol, outstanding effect advantage.Another Chinese patent disclosed " a kind of pharmaceutical composition of treating gout " (number of patent application is 200910016369.0); Be to process fine powder by Bi
, Rhizoma Alismatis, Radix Angelicae Sinensis, Radix Notoginseng, Rhizoma Chuanxiong, Herba Asari, Flos Carthami, Poria, the Radix Rehmanniae, Rhizoma Et Radix Notopterygii, Radix Angelicae Dahuricae (Radix Heraclei Scabridi), Radix Gentianae Macrophyllae, Radix Stephaniae Tetrandrae, Cortex Eucommiae carbon, Herba Taxilli, Radix Glycyrrhizae, Fructus Schisandrae Chinensis, Cortex Phellodendri, Cornu Cervi Pantotrichum, Rhizoma Corydalis, Herba Ardisiae Japonicae, Fructus Forsythiae, Rhizoma Coptidis, the Radix Paeoniae Alba, Herba Lycopodii, mullet bone, the Rhizoma Atractylodis Macrocephalae, Herba speranskiae tuberculatae, Radix Dipsaci, Rhizoma Drynariae, Radix Ampelopsis, Herba Artemisiae Anomalae, Semen Platycladi, Ramulus Cinnamomi, Herba Ephedrae, Ramulus Mori, Cortex Moutan, Radix Paeoniae Rubra, Caulis Lonicerae, Semen Coicis, the Rhizoma Anemarrhenae, Radix Notoginseng and Cornu Cervi Pantotrichum; Surplus person fries in shallow oil into decoction; Remove medicinal residues; Concentrate the back to decoction and under the cryogenic conditions about 70 ℃, be dried into solid; Process fine powder, two kinds of fine powder mix homogeneously are processed Chinese medicine powder; Above-mentioned Chinese medicine powder of processing and aspirin, sodium bicarbonate, indometacin medicated powder mix homogeneously are mixed with pharmaceutical composition.
Summary of the invention
Technical problem to be solved by this invention provides a kind of taking convenience, and has effects such as clearing away heat and promoting diuresis, uric acid reducing, cooling blood for hemostasis, blood circulation promoting and blood stasis dispelling, detoxifcation, sharp joint, can treat the medicated tea of goat.
The technical scheme that the present invention taked is a kind of medicated tea of treating goat of invention:
Its scheme one: be to process by the raw material of following weight share:
Bright moon grass [Angelica keiskei koidzmi] 1-3
Herba Plantaginis [Plantago asiatica L. or Plantago major L. or Plantago depressa Willd.] 1-3;
The additional aspects one of its scheme one: be to process by the raw material of following weight share:
Bright moon grass 1 Herba Plantaginis 3;
The additional aspects two of its scheme one: be to process by the raw material of following weight share:
Bright moon grass 3 Herba Plantaginiss 1;
The additional aspects three of its scheme one: be to process by the raw material of following weight share:
Bright moon grass 1 Herba Plantaginis 1.
Its scheme two: be to process by the raw material of following weight share:
Bright moon grass 1-3 Herba Plantaginis 1-3
Semen Cassiae [Cassia obtusifolia L. or Cassia tora L.] 1-3;
The additional aspects one of its scheme two: be to process by the raw material of following weight share:
Bright moon grass 1 Herba Plantaginis 3 Semen Cassiaes 3;
The additional aspects two of its scheme two: be to process by the raw material of following weight share:
Bright moon grass 3 Herba Plantaginiss 1 Semen Cassiae 1;
The additional aspects three of its scheme two: be to process by the raw material of following weight share:
Bright moon grass 3 Herba Plantaginiss 1 Semen Cassiae 3;
The additional aspects four of its scheme two: be to process by the raw material of following weight share:
Bright moon grass 1 Herba Plantaginis 3 Semen Cassiaes 1;
The additional aspects five of its scheme two: be to process by the raw material of following weight share:
Bright moon grass 1 Herba Plantaginis 1 Semen Cassiae 1.
Its scheme three: be to process by the raw material of following weight share:
Bright moon grass 1-3 Herba Plantaginis 1-3 Semen Cassiae 1-3
Folium Nelumbinis [Nelumbo nucifera Gaertn.] 1-3;
The additional aspects one of its scheme three: be to process by the raw material of following weight share:
Bright moon grass 1 Herba Plantaginis 3 Semen Cassiaes 3 Folium Nelumbinis 1;
The additional aspects two of its scheme three: be to process by the raw material of following weight share:
Bright moon grass 3 Herba Plantaginiss 1 Semen Cassiae 1 Folium Nelumbinis 3;
The additional aspects three of its scheme three: be to process by the raw material of following weight share:
Bright moon grass 3 Herba Plantaginiss 1 Semen Cassiae 3 Folium Nelumbinis 3;
The additional aspects four of its scheme three: be to process by the raw material of following weight share:
Bright moon grass 1 Herba Plantaginis 3 Semen Cassiaes 1 Folium Nelumbinis 1;
The additional aspects five of its scheme three: be to process by the raw material of following weight share:
Bright moon grass 1 Herba Plantaginis 1 Semen Cassiae 1 Folium Nelumbinis 1.
Its scheme four: be to process by the raw material of following weight share:
Bright moon grass 1-3 Herba Plantaginis 1-3 Semen Cassiae 1-3 Folium Nelumbinis 1-3
Flower of Radix Notoginseng [Panax pseudoginseng Wall.var.notoginseng (Burkill) Hoo et Tseng] 1-3.
The additional aspects one of its scheme four: be to process by the raw material of following weight share:
Bright moon grass 1 Herba Plantaginis 3 Semen Cassiaes 3
Folium Nelumbinis 1 flower of Radix Notoginseng 1;
The additional aspects two of its scheme four: be to process by the raw material of following weight share:
Bright moon grass 3 Herba Plantaginiss 1 Semen Cassiae 1
Folium Nelumbinis 3 flower of Radix Notoginseng 3;
The additional aspects three of its scheme four: be to process by the raw material of following weight share:
Bright moon grass 3 Herba Plantaginiss 1 Semen Cassiae 3
Folium Nelumbinis 3 flower of Radix Notoginseng 3;
The additional aspects four of its scheme four: be to process by the raw material of following weight share:
Bright moon grass 1 Herba Plantaginis 3 Semen Cassiaes 1
Folium Nelumbinis 1 flower of Radix Notoginseng 3;
The additional aspects five of its scheme four: be to process by the raw material of following weight share:
Bright moon grass 1 Herba Plantaginis 1 Semen Cassiae 1
Folium Nelumbinis 1 flower of Radix Notoginseng 1.
Its scheme five: be to process by the raw material of following weight share:
Bright moon grass 1-3 Herba Plantaginis 1-3 Semen Cassiae 1-3
Folium Nelumbinis 1-3 flower of Radix Notoginseng 1-3
Rhizoma Smilacis Glabrae [Smilax glabra Roxb.] 1-3.
The additional aspects one of its scheme five: be to process by the raw material of following weight share:
Bright moon grass 1 Herba Plantaginis 3 Semen Cassiaes 3
Folium Nelumbinis 1 flower of Radix Notoginseng 1 Rhizoma Smilacis Glabrae 3;
The additional aspects two of its scheme five: be to process by the raw material of following weight share:
Bright moon grass 3 Herba Plantaginiss 1 Semen Cassiae 1
Folium Nelumbinis 3 flower of Radix Notoginseng 3 Rhizoma Smilacis Glabraes 1;
The additional aspects three of its scheme five: be to process by the raw material of following weight share:
Bright moon grass 3 Herba Plantaginiss 1 Semen Cassiae 3
Folium Nelumbinis 3 flower of Radix Notoginseng 3 Rhizoma Smilacis Glabraes 1;
The additional aspects four of its scheme five: be to process by the raw material of following weight share:
Bright moon grass 1 Herba Plantaginis 3 Semen Cassiaes 1
Folium Nelumbinis 1 flower of Radix Notoginseng 3 Rhizoma Smilacis Glabraes 3;
The additional aspects five of its scheme five: be to process by the raw material of following weight share:
Bright moon grass 1 Herba Plantaginis 1 Semen Cassiae 1
Folium Nelumbinis 1 flower of Radix Notoginseng 1 Rhizoma Smilacis Glabrae 1.
Its manufacture method is: said medicine is carried out drying, pulverizing respectively, and mix homogeneously adopts conventional production process of bagged tea then, and bagged medicine tea, every bag of 10g are processed in pack.Also can said medicine be carried out active ingredient according to conventional method and extract, then, process dissolved granule.
The medicated tea of treatment goat of the present invention; The Herba Plantaginis of the bright moon grass of employing pathogenic fire purging, removing heat from blood and clearing away heat and promoting diuresis, eliminating dampness by diuresis is as monarch drug; The Semen Cassiae that is aided with clearing away heat to improve acuity of vision, the Rhizoma Smilacis Glabrae in the Folium Nelumbinis of clearing away summer-heat, cooling blood for hemostasis and the flower of Radix Notoginseng of blood circulation promoting and blood stasis dispelling and detoxifcation, dehumidifying, sharp joint, all medicines share; Have effects such as clearing away heat and promoting diuresis, uric acid reducing, cooling blood for hemostasis, blood circulation promoting and blood stasis dispelling, detoxifcation, dehumidifying, sharp joint, so can treat gout.Simultaneously, the medicated tea of treatment goat of the present invention is processed bagged medicine tea, thereby, its taking convenience.
In addition, because the bright moon grass has effects such as blood pressure lowering, blood sugar lowering, flower of Radix Notoginseng has effects such as two-ways regulation blood glucose, blood fat reducing, so the present invention also has effects such as blood pressure lowering, blood fat reducing and blood sugar lowering.
The medicated tea of treatment goat of the present invention is selected the patient of the different state of an illness, case history, age, sex, from being in hospital and goat case 42 examples are selected in the internal medicine outpatient service, carries out clinical experiment.
One, diagnostic criteria
(1), Western medicine diagnose standard: the standard of formulating with reference to American Rheumatism Association 1997:
1. the acute arthritis outbreak reaches a climax more than 1 time and in 24 hours; 2. acute inflammation is confined to indivedual joints; 3. whole joint is kermesinus; 4. the 1st metatarsophalangeal joints swells and ache; 5. one-sided sole of the foot joint acute inflammation; The tophus that 6. suspicious confirmation is arranged; 7. hyperuricemia; 8. asymmetry arthroncus; 9. outbreak can stop voluntarily.
At least possess wherein 4, and get rid of secondary gout, can be diagnosed as the constitutional acute gout.
(2), the tcm diagnosis standard: tcm diagnosis is an arthromyodynia, the damp and hot numbness of dialectical genus resistance card, disease sees redness and swelling of joints burning pain, limitation of activity, it is hot, thirsty to occur together, hyperhidrosis, dim complexion (is many with the sallow), yellow urine, yellow fur, slippery and rapid pulse etc.
Two, physical data
The observation case that meets diagnosis and include standard in is totally 42 wherein male 32 examples, women 10 examples, 32～48 years old age, average 40 years old; The course of disease 2～15 years, average out to 8 years.
Three, exclusion standard
1. 65 years old age < 18 years old or >, trimester of pregnancy or women breast-feeding their children, allergic constitution and to this medicine allergy sufferers; 2. merge serious primary disease such as cerebrovascular, cardiovascular, liver, kidney and hemopoietic system, the psychotic; 3. lopsided, stiff, the disability person of arthritis severe in late period; 4. do not meet the standard of including in, by the regulation medication, or data is not congruent affects the treatment or safety judgement person.
Four, efficacy assessment standard
Reference " new Chinese medicine clinical research guideline " [Ministry of Health of the People's Republic of China. new Chinese medicine clinical research guideline; The 2nd volume (S). Beijing: Ministry of Health of the People's Republic of China prints; 1995.] middle curative effect determinate standard; The symptom complete obiteration, joint function recovery is normal, and main physico-chemical examination index normally is a clinical cure; Cardinal symptom disappears, and function of joint is recovered basically, and main physico-chemical examination index is basic to be produce effects normally; Cardinal symptom disappears basically, and main function of joint and main physical and chemical index make moderate progress to effectively; With the treatment before compare each side all do not have obviously be improved as invalid.
Five, Therapeutic Method
By early, middle and late, divides three times (restraining with 10) to brew with boiled water the medicated tea of treatment goat of the present invention at every turn, be used as tea and drink, 15 days is a course of treatment, adds up curative effect after 3 courses of treatment.During the treatment, withdraw the medicine of other treatment gout, forbid high purine diet, maror and drinks etc.
Six, therapeutic effect
The difference of each scheme according to the present invention; The additional aspects five (that is: bright moon grass, Herba Plantaginis, Semen Cassiae, Folium Nelumbinis, flower of Radix Notoginseng and Rhizoma Smilacis Glabrae equal shares are processed) of additional aspects three of this experiment employing scheme one (that is: bright moon grass and Herba Plantaginis equal shares are processed) and scheme five; Selected case is divided into two groups at random, and its curative effect statistics sees the following form.
The curative effect statistical table
Show that by above-mentioned statistical data the medicated tea of treatment goat of the present invention has curative effect preferably to gout, total effective rate reaches 88.1%.
The specific embodiment
Embodiment one:
Get bright moon grass 1kg, Herba Plantaginis 3kg, carry out drying and pulverizing respectively, and mix homogeneously, then, adopting conventional production process of bagged tea, bagged medicine tea, every bag of 10g are processed in pack.
When drinking, by early, middle and late, divide three times (at every turn with 10 grams) to brew with boiled water, be used as tea and drink, 15 days is a course of treatment, and the goat patient of the general state of an illness need drink 1-2 the course of treatment, and the goat patient that the state of an illness is comparatively serious need drink 3-5 the course of treatment.Drink during the treatment, withdraw the medicine of other treatment gout, forbid high purine diet, maror and drinks etc.
Embodiment two:
Get bright moon grass 3kg, Herba Plantaginis 1kg, carry out drying and pulverizing respectively, and mix homogeneously, then, adopting conventional production process of bagged tea, bagged medicine tea, every bag of 10g are processed in pack.
Other is identical with embodiment one.
Embodiment three:
Get bright moon grass 1kg, Herba Plantaginis 1kg, carry out drying and pulverizing respectively, and mix homogeneously, then, adopting conventional production process of bagged tea, bagged medicine tea, every bag of 10g are processed in pack.
Other is identical with embodiment one.
Embodiment four:
Get bright moon grass 1kg, Herba Plantaginis 3kg, Semen Cassiae 3kg, carry out drying and pulverizing respectively, and mix homogeneously, then, adopting conventional production process of bagged tea, bagged medicine tea, every bag of 10g are processed in pack.
Other is identical with embodiment one.
Embodiment five:
Get bright moon grass 3kg, Herba Plantaginis 1kg, Semen Cassiae 1kg, carry out drying and pulverizing respectively, and mix homogeneously, then, adopting conventional production process of bagged tea, bagged medicine tea, every bag of 10g are processed in pack.
Other is identical with embodiment one.
Embodiment six:
Get bright moon grass 3kg, Herba Plantaginis 1kg, Semen Cassiae 3kg, carry out drying and pulverizing respectively, and mix homogeneously, then, adopting conventional production process of bagged tea, bagged medicine tea, every bag of 10g are processed in pack.
Other is identical with embodiment one.
Embodiment seven:
Get bright moon grass 1kg, Herba Plantaginis 3kg, Semen Cassiae 1kg, carry out drying and pulverizing respectively, and mix homogeneously, then, adopting conventional production process of bagged tea, bagged medicine tea, every bag of 10g are processed in pack.
Other is identical with embodiment one.
Embodiment eight:
Get bright moon grass 1kg, Herba Plantaginis 1kg, Semen Cassiae 1kg, carry out drying and pulverizing respectively, and mix homogeneously, then, adopting conventional production process of bagged tea, bagged medicine tea, every bag of 10g are processed in pack.
Other is identical with embodiment one.
Embodiment nine:
Get bright moon grass 1kg, Herba Plantaginis 3kg, Semen Cassiae 3kg, Folium Nelumbinis 1kg, carry out drying and pulverizing respectively, and mix homogeneously, then, adopting conventional production process of bagged tea, bagged medicine tea, every bag of 10g are processed in pack.
Other is identical with embodiment one.
Embodiment ten:
Get bright moon grass 3kg, Herba Plantaginis 1kg, Semen Cassiae 1kg, Folium Nelumbinis 3kg, carry out drying and pulverizing respectively, and mix homogeneously, then, adopting conventional production process of bagged tea, bagged medicine tea, every bag of 10g are processed in pack.
Other is identical with embodiment one.
Embodiment 11:
Get bright moon grass 3kg, Herba Plantaginis 1kg, Semen Cassiae 3kg, Folium Nelumbinis 3kg, carry out drying and pulverizing respectively, and mix homogeneously, then, adopting conventional production process of bagged tea, bagged medicine tea, every bag of 10g are processed in pack.
Other is identical with embodiment one.
Embodiment 12:
Get bright moon grass 1kg, Herba Plantaginis 3kg, Semen Cassiae 1kg, Folium Nelumbinis 1kg, carry out drying and pulverizing respectively, and mix homogeneously, then, adopting conventional production process of bagged tea, bagged medicine tea, every bag of 10g are processed in pack.
Other is identical with embodiment one.
Embodiment 13:
Get bright moon grass 1kg, Herba Plantaginis 1kg, Semen Cassiae 1kg, Folium Nelumbinis 1kg, carry out drying and pulverizing respectively, and mix homogeneously, then, adopting conventional production process of bagged tea, bagged medicine tea, every bag of 10g are processed in pack.
Other is identical with embodiment one.
Embodiment 14:
Get bright moon grass 1kg, Herba Plantaginis 3kg, Semen Cassiae 3kg, Folium Nelumbinis 1kg, flower of Radix Notoginseng 1kg, carry out drying and pulverizing respectively, and mix homogeneously, then, adopting conventional production process of bagged tea, bagged medicine tea, every bag of 10g are processed in pack.
Other is identical with embodiment one.
Embodiment 15:
Get bright moon grass 3kg, Herba Plantaginis 1kg, Semen Cassiae 1kg, Folium Nelumbinis 3kg, flower of Radix Notoginseng 3kg, carry out drying and pulverizing respectively, and mix homogeneously, then, adopting conventional production process of bagged tea, bagged medicine tea, every bag of 10g are processed in pack.
Other is identical with embodiment one.
Embodiment 16:
Get bright moon grass 3kg, Herba Plantaginis 1kg, Semen Cassiae 3kg, Folium Nelumbinis 3kg, flower of Radix Notoginseng 3kg, carry out drying and pulverizing respectively, and mix homogeneously, then, adopting conventional production process of bagged tea, bagged medicine tea, every bag of 10g are processed in pack.
Other is identical with embodiment one.
Embodiment 17:
Get bright moon grass 1kg, Herba Plantaginis 3kg, Semen Cassiae 1kg, Folium Nelumbinis 1kg, flower of Radix Notoginseng 3kg, carry out drying and pulverizing respectively, and mix homogeneously, then, adopting conventional production process of bagged tea, bagged medicine tea, every bag of 10g are processed in pack.
Other is identical with embodiment one.
Embodiment 18:
Get bright moon grass 1kg, Herba Plantaginis 1kg, Semen Cassiae 1kg, Folium Nelumbinis 1kg, flower of Radix Notoginseng 1kg, carry out drying and pulverizing respectively, and mix homogeneously, then, adopting conventional production process of bagged tea, bagged medicine tea, every bag of 10g are processed in pack.
Other is identical with embodiment one.
Embodiment 19:
Get bright moon grass 1kg, Herba Plantaginis 3kg, Semen Cassiae 3kg, Folium Nelumbinis 1kg, flower of Radix Notoginseng 1kg, Rhizoma Smilacis Glabrae 3kg, carry out drying and pulverizing respectively, and mix homogeneously, then, adopting conventional production process of bagged tea, bagged medicine tea, every bag of 10g are processed in pack.
Other is identical with embodiment one.
Embodiment 20:
Get bright moon grass 3kg, Herba Plantaginis 1kg, Semen Cassiae 1kg, Folium Nelumbinis 3kg, flower of Radix Notoginseng 3kg, Rhizoma Smilacis Glabrae 1kg, carry out drying and pulverizing respectively, and mix homogeneously, then, adopting conventional production process of bagged tea, bagged medicine tea, every bag of 10g are processed in pack.
Other is identical with embodiment one.
Embodiment 21:
Get bright moon grass 3kg, Herba Plantaginis 1kg, Semen Cassiae 3kg, Folium Nelumbinis 3kg, flower of Radix Notoginseng 1kg, Rhizoma Smilacis Glabrae 1kg, carry out drying and pulverizing respectively, and mix homogeneously, then, adopting conventional production process of bagged tea, bagged medicine tea, every bag of 10g are processed in pack.
Other is identical with embodiment one.
Embodiment 22:
Get bright moon grass 1kg, Herba Plantaginis 3kg, Semen Cassiae 1kg, Folium Nelumbinis 1kg, flower of Radix Notoginseng 3kg, Rhizoma Smilacis Glabrae 3kg, carry out drying and pulverizing respectively, and mix homogeneously, then, adopting conventional production process of bagged tea, bagged medicine tea, every bag of 10g are processed in pack.
Other is identical with embodiment one.
Embodiment 23:
Get bright moon grass 1kg, Herba Plantaginis 1kg, Semen Cassiae 1kg, Folium Nelumbinis 1kg, flower of Radix Notoginseng 1kg, Rhizoma Smilacis Glabrae 1kg, carry out drying and pulverizing respectively, and mix homogeneously, then, adopting conventional production process of bagged tea, bagged medicine tea, every bag of 10g are processed in pack.
Other is identical with embodiment one.
Claims (5)
1. medicated tea of treating goat is characterized in that being processed by following raw materials in weight:
Bright moon grass 1-3 Herba Plantaginis 1-3.
2. according to the medicated tea of the said treatment goat of claim 1, it is characterized in that processing by following raw materials in weight:
Bright moon grass 1-3 Herba Plantaginis 1-3 Semen Cassiae 1-3.
3. according to the medicated tea of the said treatment goat of claim 2, it is characterized in that processing by following raw materials in weight:
Bright moon grass 1-3 Herba Plantaginis 1-3 Semen Cassiae 1-3 Folium Nelumbinis 1-3.
4. according to the medicated tea of the said treatment goat of claim 3, it is characterized in that processing by following raw materials in weight:
Bright moon grass 1-3 Herba Plantaginis 1-3 Semen Cassiae 1-3
Folium Nelumbinis 1-3 flower of Radix Notoginseng 1-3.
5. according to the medicated tea of the said treatment goat of claim 4, it is characterized in that processing by following raw materials in weight:
Bright moon grass 1-3 Herba Plantaginis 1-3 Semen Cassiae 1-3
Folium Nelumbinis 1-3 flower of Radix Notoginseng 1-3 Rhizoma Smilacis Glabrae 1-3.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2011100473355A CN102133271B (en) | 2011-02-24 | 2011-02-24 | Herbal tea for treating gout |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2011100473355A CN102133271B (en) | 2011-02-24 | 2011-02-24 | Herbal tea for treating gout |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN102133271A CN102133271A (en) | 2011-07-27 |
| CN102133271B true CN102133271B (en) | 2012-02-29 |
Family
ID=44293284
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2011100473355A Expired - Fee Related CN102133271B (en) | 2011-02-24 | 2011-02-24 | Herbal tea for treating gout |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN102133271B (en) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104012729A (en) * | 2014-06-11 | 2014-09-03 | 杨平 | Tea substitute bag capable of lowering uric acid |
| CN104082743A (en) * | 2014-07-09 | 2014-10-08 | 刘友章 | Healthcare food for curing acute gouty arthritis and preparation method thereof |
| CN105687351A (en) * | 2014-11-27 | 2016-06-22 | 韦健宁 | Chinese medicinal composition for treatment of gout |
| CN104664369B (en) * | 2015-01-14 | 2016-08-24 | 厦门医学高等专科学校 | A kind of Radix et Rhizoma Gynurae divaricatae health food of blood pressure lowering uric acid resisting and preparation method thereof |
| CN106538793A (en) * | 2016-12-30 | 2017-03-29 | 吉林大学 | A kind of uric acid resisting health tea and preparation method thereof |
| CN110787265A (en) * | 2019-11-19 | 2020-02-14 | 蔡荣江 | Formula and method for treating gout disease |
| CN110772611A (en) * | 2019-12-13 | 2020-02-11 | 赵洪勇 | Traditional Chinese medicine composition for regulating gout |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1290551A (en) * | 1999-10-05 | 2001-04-11 | 岳学华 | Method for preparing medicinal liquid for curing angiocardiopathy |
| CN1471947A (en) * | 2002-07-30 | 2004-02-04 | 荣 邓 | Natural weight-reducing medicine |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS57102812A (en) * | 1980-12-11 | 1982-06-26 | Tadashi Kamibayashi | Preparation of aroma composition |
-
2011
- 2011-02-24 CN CN2011100473355A patent/CN102133271B/en not_active Expired - Fee Related
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1290551A (en) * | 1999-10-05 | 2001-04-11 | 岳学华 | Method for preparing medicinal liquid for curing angiocardiopathy |
| CN1471947A (en) * | 2002-07-30 | 2004-02-04 | 荣 邓 | Natural weight-reducing medicine |
Non-Patent Citations (2)
| Title |
|---|
| 唐劭.曹克光中西医结合治疗痛风经验.《江西中医药》.2007,(第11期), * |
| 宋平.曹克光治疗痛风及高尿酸血症经验.《中医药临床杂志》.2005,(第05期), * |
Also Published As
| Publication number | Publication date |
|---|---|
| CN102133271A (en) | 2011-07-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101703708B (en) | Chinese medicinal preparation for treating rheumatoid arthritis and gout, and preparation method thereof | |
| CN102772745B (en) | Chinese medicinal preparation for treating cancer and preparation method thereof | |
| CN102133271B (en) | Herbal tea for treating gout | |
| CN101961480A (en) | Traditional Chinese medicinal composition for treating hematochezia and preparation method thereof | |
| CN101011544A (en) | Gout rapid recovery pill(capsule) and preparation technique thereof | |
| CN102940785B (en) | Traditional Chinese medicine composition for treating vertigo | |
| CN101095768A (en) | Chinese traditional medicine capsule for treating primary hypertension for persons in middle and old age | |
| CN101757591A (en) | Traditional Chinese medicine composition for treating chronic colitis and protitis | |
| CN103341127A (en) | Traditional Chinese medicine for treating uremia along with hematodialysis and preparation method | |
| CN105031454A (en) | Medicine for treating pulmonary tuberculosis | |
| CN105106758A (en) | Traditional Chinese medicine composition for treating phlegm and blood stasis type dizziness | |
| CN104173950A (en) | Chinese herbal medicine composition for treating prostatic cancer | |
| CN1246031C (en) | Chinese patent drug-Fuyan capsdule for treating chronic pelvic inflammation | |
| CN101961448A (en) | Chinese medicament for treating diabetic gout | |
| CN102805795B (en) | Chinese medicinal composition for treating acute soft tissue injury of chest and hypochondrium and application thereof | |
| CN100394976C (en) | Chinese medicine for withdrawal of drug dependence | |
| CN102614344B (en) | Traditional Chinese medicine for treating qi-blood deficiency periodontitis, preparation method and administration method thereof | |
| CN102552520A (en) | Blood circulation-promoting and pain-stopping medicament for treating chest stuffiness and pains and preparation process and application thereof | |
| CN102552519A (en) | Chinese medicine composition for activating blood and stopping pain, preparation process and application | |
| CN103041233A (en) | Pharmaceutical composition for treating infantile diarrhea and preparation method thereof | |
| CN103800561A (en) | Traditional Chinese medicine for treating renal hematuria | |
| CN103735741A (en) | Traditional Chinese medicinal composition for treating gout | |
| CN100388931C (en) | Medicine for treating pelvic inflammation and preparation method thereof | |
| CN102100853B (en) | Traditional Chinese medicine for treating gout and preparation method thereof | |
| CN104800675A (en) | Medicament for treating active ulcerative colitis |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20120229 |
|
| CF01 | Termination of patent right due to non-payment of annual fee |